We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NF-κB signaling in prostate cancer: a promising therapeutic target?
- Authors
Jain, Garima; Cronauer, Marcus V; Schrader, Mark; Möller, Peter; Marienfeld, Ralf B
- Abstract
Prostate carcinoma (PCa) displays a wide variety of genetic alterations, versatile expression profiles as well as cell surface markers. Despite this heterogeneity, a common treatment for advanced PCa is androgen deprivation therapy (ADT). ADT targets the androgen receptor-a member of the nuclear receptor superfamily-which is required for development and function of the prostate and critical for PCa growth and survival. After an initial regression of the tumor during ADT, a large fraction of tumors progress to so-called castration-resistant prostate carcinoma (CRPca) which is highly resistant toward chemotherapy. The ensuing high mortality rates illustrate the importance of novel therapeutic targets for CRPCa. The transcription factor NF-κB was recently proposed as such a potential target for therapeutic intervention in CRPCa. Although NF-κB is essential for the regulation of innate and adaptive immunity recent data suggest a role of NF-κB in cancer initiation and progression. However, the exact function of NF-κB signaling in PCa is still a matter of debate. Here, we review known roles of NF-κB signaling in PCa and emphasize the crosstalk of NF-κB and androgen receptor signaling. Finally, we discuss potential therapeutic relevance of blocking NF-κB in PCa.
- Publication
World journal of urology, 2012, Vol 30, Issue 3, p303
- ISSN
1433-8726
- Publication type
Journal Article
- DOI
10.1007/s00345-011-0792-y